GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lytix Biopharma AS (STU:6BG) » Definitions » Net Policyholder Benefits/Claims

Lytix Biopharma AS (STU:6BG) Net Policyholder Benefits/Claims


View and export this data going back to 2021. Start your Free Trial

What is Lytix Biopharma AS Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


Lytix Biopharma AS Business Description

Industry
Traded in Other Exchanges
Address
Sandakerveien 138, Oslo, NOR, 0484
Lytix Biopharma AS is a clinical-stage biotech company engaged in developing cancer immunotherapies aimed at activating the patient's immune system to fight cancer. Its products, LTX-401 and LTX-315, are in the pipeline. The company operates in Norway and the USA, majority of revenue is from the USA.